Last reviewed · How we verify

NCT06900439

Exploring Glycemic Responses Through Continuous Monitoring in a Healthy Population

Completed NA Last updated 8 September 2025
What this trial tests

NA trial testing Dietary Intervention in Gut Microbiome in 1,189 participants. Completed in 31 May 2025.

Timeline
21 March 2025
Primary endpoint
31 May 2025
31 May 2025

Quick facts

Lead sponsorZoe Global Limited
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment1,189
Start date21 March 2025
Primary completion31 May 2025
Estimated completion31 May 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Zoe Global Limited

Who can join

18 and older, any sex, with Gut Microbiome or Glucose Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PREDICT REFINE is a sub-study of PREDICT 3 with the primary aim of exploring glycemic responses through continuous glucose monitoring in a healthy population. The study will explore glycemic responses to a standardised test meal before and after a personalised dietary programme. The sub-study will include wearing a Continuous Glucose Monitor for 14 days, collecting information around diet and health, providing a stool sample, and consuming a standardised test meal. By conducting this study researchers hope to better understand Continuous Glucose Monitoring accuracy and variability in healthy individuals, the impact of diet on glycemic responses over time, and potential mechanisms by which changes in microbiome health may influence glycemic control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dietary Intervention

Trials testing the same drug.

Other recruiting trials for Gut Microbiome

Currently open trials in the same condition.

Other Zoe Global Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06900439.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing